Novus Biologicals™ CXCL9/MIG Antibody (Novimmune patent anti-CXCL9) - Humanized, Novus Biologicals™

Human Monoclonal Antibody

Product Code	Brand	Quantity
30045810	Novus Biologicals™ NBP3-28413-50ug	50 μg
30045612	Novus Biologicals™ NBP3-28413-100ug	100 μg
30047345	Novus Biologicals™ NBP3-28413-1mg	1 mg

Description

CXCL9/MIG Monoclonal antibody specifically detects CXCL9/MIG in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay

Specifications

• Antigen: CXCL9/MIG
• Applications: Flow Cytometry, ELISA, Functional Assay
• Conjugate: Unconjugated
• Host Species: Human
• Research Discipline: Biologically Active Proteins, Chemokines and Cytokines, Signal Transduction
• Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
• Gene Alias: chemokine (C-X-C motif) ligand 9, CMK, crg-10, C-X-C motif chemokine 9, Gamma-interferon-induced monokine, Humig, MIGSmall-inducible cytokine B9, monokine induced by gamma interferon, SCYB9Monokine induced by interferon-gamma
• Immunogen: CXCL9
• Primary or Secondary: Primary
• Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.

• Clone: Novimmune patent anti-CXCL9
• Classification: Monoclonal
• Form: Purified
• Regulatory Status: RUO
• Target Species: Human
• Gene Accession No.: Q07325
• Gene ID (Entrez): 4283
• Isotype: IgG1
• Purification Method: Protein A purified
• Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.